ArcStone Securities & Investments Corp. has officially unveiled plans to acquire the New York-based, FINRA-registered broker-dealer Arcview Capital LLC. ArcStone’s subsidiary, ArcStone US Corp., is the key player in this strategic acquisition, positioning the company to redefine the financial service sector with an unparalleled emphasis on entrepreneurship and client services.
Arcview Capital has historically been a beacon for the growth of cannabis and other adaptogenic plant-based businesses, largely credited to its equity crowdfunding platform. With this acquisition, Arcview’s alliance with industry giant, The Arcview Group, remains unshaken. The merger will further streamline investments in the rapidly expanding cannabis sector.
Catch Jeffrey Finkle, CEO of The Arcview Group at the Benzinga Cannabis Capital Conference, the place where deals get done. The event is returning to Chicago this Sept 27-28 for its 17th edition. Get your tickets today before prices increase and secure a spot at the epicenter of cannabis investment and branding.
Laying out the blueprint for this acquisition, Michael Astone, CEO of ArcStone, said, “This acquisition is instrumental in redefining the spectrum of services available to corporate issuers not just in the US but also in Canada and other capital markets.” He further outlined the merger’s intent to strengthen relationships across the North-South economic divide, especially in budding sectors such as cannabis, life sciences and technology.
The collaboration doesn’t end with the acquisition. ArcStone and Arcview are also looking into potential alliances that would allow ArcStone to tap into Arcview’s vast brand and ecosystem, significantly bolstering ArcStone’s Cannabis and wider banking operations. Since its inception in 2011, Arcview has been a cornerstone in the cannabis domain, known for organizing premier events that witness a plethora of investors, clients, and professionals.
Jeffrey Finkle, CEO of The Arcview Group, expressed his anticipation for the merger, “Our collaboration will propel the business to unmatched heights in the cannabis investment domain.”
Michael Astone further announced plans for ArcStone to establish a top-tier advisory board, including former public CEOs, family offices, and other industry insiders. “We are primed to unveil a range of strategic investments that aim at building a robust ecosystem of industry partners,” Michael affirmed.
The transaction remains in its final stages, with specific conditions still to be met and essential regulatory approvals pending.
